Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
Clinical trial NCT06008808 · RECRUITING
Trial details
- NCT number
- NCT06008808
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-07
- Primary completion
- 2027-09-08
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.